(2R,3R,4S)-3-Acetamido-2-((1R‘,2R‘)-2,3-dihydroxy-1-methoxypropyl)-4-guanidino-3,4-dihydro-2H-pyran-6-carboxylic acid

Laninamivir (CAS 203120-17-6) reference standard from WITEGA Laboratorien Berlin-Adlershof GmbH enables precise LC-MS/MS and GC-MS quantification. This neuraminidase inhibitor reference standard supports traceability, robust calibration, method validation, and confirmatory analysis. Laboratories choose it for reliable performance and consistent results.

Produced and distributed by WITEGA Laboratorien Berlin-Adlershof GmbH, this material comes with clear documentation for compliance and audits. You can integrate it into instrument calibration, recovery checks, and matrix-matched calibration. Therefore, you streamline workflows while keeping defensible data and consistent accuracy.

Typical applications include:

• Regulated laboratories requiring traceable calibration and system suitability.
• Pharmaceutical research exploring antiviral metabolism and pharmacokinetics.
• Residue control and surveillance programs in complex matrices.
• Metabolism studies and biotransformation profiling.
• Multi-residue method development and validation across platforms.

Key benefits:

• Optimized for LC-MS/MS and GC-MS response and selectivity.
• Suitable for calibration curves, spiking, and QC samples.
• Excellent batch-to-batch consistency with transparent traceability.
• Compatible with confirmatory analysis and orthogonal methods.

Use Laninamivir (CAS 203120-17-6) to build linear calibration, verify identification points, and confirm results across matrices. Furthermore, the reference standard helps reduce uncertainty and improves decision limits in routine testing. In addition, support teams at WITEGA Laboratorien Berlin-Adlershof GmbH assist with documentation and ordering so you can focus on results.

You can download your Safety Data Sheet for VS017

For other languages please contact us: witega@witega.de